AU2001256507A1 - Modulation - Google Patents
ModulationInfo
- Publication number
- AU2001256507A1 AU2001256507A1 AU2001256507A AU5650701A AU2001256507A1 AU 2001256507 A1 AU2001256507 A1 AU 2001256507A1 AU 2001256507 A AU2001256507 A AU 2001256507A AU 5650701 A AU5650701 A AU 5650701A AU 2001256507 A1 AU2001256507 A1 AU 2001256507A1
- Authority
- AU
- Australia
- Prior art keywords
- modulation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/12—Ophthalmic agents for cataracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20449300P | 2000-05-16 | 2000-05-16 | |
US60204493 | 2000-05-16 | ||
PCT/GB2001/002140 WO2001088122A2 (en) | 2000-05-16 | 2001-05-15 | Erg modulators |
Publications (1)
Publication Number | Publication Date |
---|---|
AU2001256507A1 true AU2001256507A1 (en) | 2001-11-26 |
Family
ID=22758131
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2001256507A Abandoned AU2001256507A1 (en) | 2000-05-16 | 2001-05-15 | Modulation |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2001256507A1 (en) |
WO (1) | WO2001088122A2 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2001088124A2 (en) * | 2000-05-16 | 2001-11-22 | Ribozyme Pharmaceuticals, Inc. | Method and reagent for the inhibition of erg |
JP5009787B2 (en) * | 2004-05-07 | 2012-08-22 | ザ・ヘンリー・エム・ジャクソン・ファンデイション・フォー・ジ・アドヴァンスメント・オヴ・ミリタリー・メディシン、インコーポレイテッド | A method for diagnosing or treating prostate cancer using the ERG gene alone or in combination with other genes that are overexpressed or underexpressed in prostate cancer |
CA3007181A1 (en) * | 2014-12-12 | 2016-06-16 | Tufts University | Collagenase-derived peptides promote tissue regeneration and wound healing |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH1175871A (en) * | 1997-06-18 | 1999-03-23 | Chugai Pharmaceut Co Ltd | Cell calcification suppressing active protein and gene coding for the same protein |
US6054316A (en) * | 1999-06-25 | 2000-04-25 | Isis Pharmaceuticals Inc. | Antisense inhibition of ETs-2 expression |
-
2001
- 2001-05-15 AU AU2001256507A patent/AU2001256507A1/en not_active Abandoned
- 2001-05-15 WO PCT/GB2001/002140 patent/WO2001088122A2/en active Application Filing
Also Published As
Publication number | Publication date |
---|---|
WO2001088122A2 (en) | 2001-11-22 |
WO2001088122A3 (en) | 2002-04-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU6419701A (en) | Electropancreatography | |
AU2001262847A1 (en) | Language-understanding | |
AU2001292739A1 (en) | 1-oxorapamycins | |
AU2001254546A1 (en) | Aminopiperidines | |
AU2000267458A1 (en) | Hypercomputer | |
AU2001239310A1 (en) | Decahydro-isoquinolines | |
AU2001220246A1 (en) | Neckphone | |
AU2002211620A1 (en) | Autoanastomosis | |
AU2001258349A1 (en) | Bisacylguanidine | |
AU2001296577A1 (en) | Chlorophyllases | |
AU2001279754A1 (en) | Indoloquinazolinones | |
AU2002211128A1 (en) | Step-bike | |
AU2001285886A1 (en) | 2-guanidino-4-aryl-quinazoline | |
AU2001290931A1 (en) | Ski-snowboard | |
AU2001293852A1 (en) | Sulfonylguanidine | |
AU2001258924A1 (en) | Microsatellite-aflp | |
AU2002226346A1 (en) | 2-aryl-5-trifluoromethylpyridines | |
AU2001281921A1 (en) | Bdellosomes | |
AU2001246864A1 (en) | Hypotensors | |
AU2001291876A1 (en) | Triazolo-epothilones | |
EP1368891B8 (en) | Iq modulator | |
AU2002214354A1 (en) | Neck-phone | |
AU4620300A (en) | Can | |
AU2001295713A1 (en) | Blast-processing | |
AU2001226668A1 (en) | Crankshaft-starter-generator |